Intermittent androgen suppression with leuprolide and flutamide for prostate cancer: a pilot study

By Higano C.S.   Ellis W.   Russell K.   Lange P.H.  

Urology, Vol. 48, Iss. 5, 1996-11 ,pp. : 800-804

Elsevier

Access to resources Recommend Favorite

This study was supported by grant 6960 from the Austrian National Bank.Current status of intermittent androgen suppression in the treatment of prostate cancer - a pilot study

By Theyer G.   Hamilton G.  

Urology, Vol. 52, Iss. 3, 1998-09 ,pp. : 353-359

Elsevier

Access to resources Recommend Favorite

Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report

By Goldenberg S.L.   Bruchovsky N.   Gleave M.E.   Sullivan L.D.   Akakura K.  

Urology, Vol. 45, Iss. 5, 1995-05 ,pp. : 839-845

Elsevier

Access to resources Recommend Favorite

Predictive factors of biochemical progression in prostate cancer patients treated with intermittent androgen suppression

By de la Taille A.   Zerbib M.   Conquy S.   Amsellem-Ouazana D.   Thiounn N.   Flam T.   Saighi D.   Debre B.  

European Urology Supplements, Vol. 1, Iss. 1, 2002-01 ,pp. : 135-135

Elsevier

Access to resources Recommend Favorite

Pilot attempt of advanced prostate cancer treatment T3NxMx−1 by intermittent more complete androgen blockade

By Dutkiewicz Slawomir  

International Urology and Nephrology, Vol. 36, Iss. 3, 2004-09 ,pp. : 359-363

Springer Publishing Company

Access to resources Recommend Favorite